论文部分内容阅读
1.Introduction Chlorambucil (CHL) is used for chemotherapy of lymphocytic leukemia, ovarian and breast carcinomas, and Hodgkins disease.However, its use is limited by its toxic side effects.The carriers for drug delivery have attracted great attention and offer a promising cancer therapy strategy, as its properties of increasing drug concentration within the tumor and minimizing the drug-induced toxic side effects on normal tissues, etc.